SEC Company Response from Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704) (CLRB) — Nov 18, 2016
Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704)
Date: Nov. 18, 2016 · CIK: 0001279704 · Accession: 0001144204-16-135420
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-214198
Letter
CELLECTAR BIOSCIENCES, INC.
3301 Agriculture Drive
Madison, WI 53716
November 18, 2016
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Scot Foley
Re: Cellectar Biosciences, Inc.
Registration Statement on Form S-1
File No. 333-214198
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (Registration No. 333-214198), as amended, be accelerated so that the Registration Statement will become effective at 4:20 p.m. on November 21, 2016, or as soon as practicable thereafter.
Very truly yours,
CELLECTAR BIOSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
CELLECTAR BIOSCIENCES, INC.
3301 Agriculture Drive
Madison, WI 53716
November 18, 2016
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Scot Foley
Re:
Cellectar Biosciences, Inc.
Registration Statement on Form S-1
File No. 333-214198
Ladies and Gentlemen:
Pursuant to Rule 461(a)
under the Securities Act of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”),
hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (Registration No. 333-214198),
as amended, be accelerated so that the Registration Statement will become effective at 4:20 p.m. on November 21, 2016, or as soon
as practicable thereafter.
Very truly yours,
CELLECTAR BIOSCIENCES, INC.
By:
/s/ James Caruso
James Caruso, President and
Chief Executive Officer